Harrie Buurlage

Mr. Buurlage oversees SHINE’s operations in Europe, including the company’s siting, construction and operation of an isotope production facility there. Before joining SHINE, Mr. Buurlage was chief operating officer and then managing director of NRG, an international nuclear service provider, in the Netherlands. Among other things, he oversaw all nuclear installations, including the Dutch High Flux medical isotope production facility. Before joining NRG, Mr. Buurlage was global director of manufacturing and distribution for Covidien, where he was responsible for radiopharmaceutical isotope manufacturing and distribution at facilities in the Netherlands, United Kingdom and United States. Earlier in his career, he spent nearly 15 years at Mallinckrodt, where he served as managing director of Mallinckrodt Medical (MM) B.V., among other positions. He studied applied physics at the University of Groningen.